University Hospitals Cleveland Medical Center

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, University Hospitals Cleveland Medical Center sits in the top decile of US sponsors by registered trial count (#142 of 15,742 sponsors by registered trial count).

230 total trials 42 currently recruiting 154 completed later-stage tilt top decile by trial count

University Hospitals Cleveland Medical Center: 230 sponsored US clinical trials, 42 recruiting.

University Hospitals Cleveland Medical Center sponsors 230 registered US clinical trials on ClinicalTrials.gov, 42 of them currently recruiting, and 154 completed. 48 of these trials are in Phase 3-4 (later-stage) and 27 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Bipolar Disorder, with 6 trials.

Top-decile sponsor footprint

University Hospitals Cleveland Medical Center ranks in the top decile of sponsors by registered trial count (#142 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 52/100

154 of 181 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

230 total, page 4 of 5

COMPLETED NA

Surgical Theater's Surgery Rehearsal Platform

NCT02099318

COMPLETED NA

Optical Imaging Measurement of Intravascular Solution Efficacy Trial

NCT01743872

TERMINATED Phase 4

Pioglitazone for the Treatment of Bipolar Depression

NCT01717040

COMPLETED NA

Evaluation of a TAP Block Given During Laparoscopic Colorectal Surgery to Help Control Pain

NCT01731782

COMPLETED NA

Evaluation of a Novel Endoscopic Treatment for Achalasia

NCT01770249

TERMINATED Phase 1

Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease

NCT01560585

TERMINATED Phase 2

Use of Dexmedetomidine in Acute Stroke and Cerebral Vasospasm Interventions

NCT01845441

TERMINATED Phase 4

Gao Bipolar Spectrum Lithium/Quetiapine Study

NCT01526148

COMPLETED Phase 2

Vitamin D Supplementation in HIV Youth

NCT01523496

COMPLETED Phase 4

Asenapine in the Treatment of Older Adults With Bipolar Disorder

NCT01460290

COMPLETED

Vitamin D and HIV-Cardiovascular Disease in Children and Young Adults

NCT01410305

TERMINATED Phase 4

Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer

NCT01459666

COMPLETED NA

Breast for Success: A Family-Centered Intervention in Support of Breastfeeding Among High-risk Low-income Mothers

NCT01272661

COMPLETED Phase 3

Life 4°C Versus Optisol in Corneal Storage Media

NCT01657500

TERMINATED NA

Electrical and Formocresol Pulpotomy in Primary Molars

NCT01622153

COMPLETED NA

Effect of Sulforaphane in Broccoli Sprouts on Nrf2 Activation

NCT01315665

COMPLETED NA

Microarray Analysis of Scalp Biopsies After Minoxidil Treatment

NCT01309191

COMPLETED

Pioglitazone and Quetiapine XR Pharmacogenetic Study

NCT01342380

COMPLETED NA

Apollo Overstitch, a Treat and Resect Model

NCT01307813

COMPLETED Phase 2

Use of Rosuvastatin in HIV-Infected Subjects to Modulate Cardiovascular Risks

NCT01218802

COMPLETED NA

Feasibility Trial to Evaluate the Ability of the SuMO Tissue Access and Resection System

NCT01322737

COMPLETED Phase 4

Ziprasidone Switching in Response to Adherence and Psychotropic-Related Weight Gain Concerns Among Patients With Bipolar Disorder (Zip Ad)

NCT01293825

TERMINATED NA

Comparative Study of Biologic Mesh Versus Repair With Component Separation.

NCT01295125

COMPLETED NA

Examining the Ease of Intubation Using the Parker Flex-Tip® or a Standard Endotracheal Tube

NCT01263873

COMPLETED NA

QI Study of a Practice Facilitator's Impact in Working With Clinics on Improving Dental, Lead & Obesity Measures for Children

NCT01739166

COMPLETED NA

Customized Adherence Enhancement Plus Long-acting Injectable Antipsychotic

NCT01152697

COMPLETED NA

Study to Find Out if Intensive Diabetes Clinic and Continuous Glucose Monitors Help Teenagers With Diabetes

NCT01083433

COMPLETED

Assessing Infectious Risk and Visceral Closure in Natural Orifice Translumenal Endoscopic Surgery (NOTES)

NCT01102725

COMPLETED

Intrapartum Epidural Fentanyl/Bupivacaine Analgesia, Infant Feeding Behavior, & Breast-Feeding Outcomes

NCT01260051

COMPLETED

Ambulatory Blood Pressure Monitoring in Children

NCT01070342

COMPLETED Phase 1

Pilot Study Evaluating the Efficacy of AlloMEM After Loop Ileostomy

NCT01113736

COMPLETED Phase 2

Study of Vitamin D and Effect on Heart Disease and Insulin Resistance

NCT01093417

COMPLETED Phase 4

Daily Wear Corneal Infiltrative Event Study

NCT00937105

TERMINATED

Assessing Effectiveness of Laparoscopic Colorectal Surgical Skills

NCT01119027

COMPLETED

Cognitive Function in Adults With Cardiac Disease

NCT01043315

COMPLETED NA

Cataract Removal and Alzheimer's Disease

NCT00921297

COMPLETED Phase 2

Pilot Placebo Controlled Study With Lovaza in Cardiovascular Disease

NCT01001767

COMPLETED Phase 4

Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance

NCT00835120

COMPLETED NA

Customized Medication Adherence Enhancement for Adults With Bipolar Disorder

NCT00830310

COMPLETED Phase 2

Safety and Efficacy of Salsalate to Treat Endothelial Dysfunction in HIV-infected Adults

NCT01046682

TERMINATED NA

Breath-Actuated Nebulizer Versus Conventional Continuous-Output Nebulizer in Pediatric Asthma Patients

NCT01045174

COMPLETED NA

Feeding and Wellness Among Late Preterm Infants

NCT00470717

COMPLETED NA

Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease

NCT00791557

COMPLETED Phase 2

Safety and Efficacy of CC-10004 for Prurigo Nodularis

NCT00869089

COMPLETED NA

Treatment of Hemorrhagic Radiation Proctitis Using the Halo System

NCT01103492

COMPLETED NA

Study of a New Circular Anal Dilator

NCT00693459

COMPLETED Phase 3

Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD)

NCT00671853

COMPLETED Phase 3

Lamotrigine for Symptoms of Geriatric Bipolar Depression

NCT00621842

COMPLETED NA

Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis

NCT00573651

COMPLETED

Antiretrovirals and Rate of Progression in Carotid Artery Intima-medial Thickness in HIV

NCT00575939

← Previous Page 4 of 5 Next →

Phase Distribution

PhaseTrial count
Phase 1 14
Phase 2 13
Phase 3 16
Phase 4 32

Where University Hospitals Cleveland Medical Center enrollment is open (later-stage tilt)

42 recruiting of 230 indexed (18% open); 154 completed (67%).

Phase mix: 48 late (III/IV) vs 27 early (I/II) (later-stage heavy).

Top condition: Bipolar Disorder (6 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University Hospitals Cleveland Medical Center: open-pipeline peers nationwide

Peers matched on 230 registered trials and 18% open enrollment, not the therapeutic-area sidebar.

University Hospitals Cleveland Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 050100150200250 10%12%14%16%18%20% Total trials Recruiting share University Hospitals Cleveland Medical CenterBrown UniversityUniversity of IowaGeorgetown UniversityHenry Ford Health SystemBurke Medical Research InstituteGrand Valley State UniversityImunonInventisBio Co.
University Hospitals Cleveland Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University Hospitals Cleveland Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 230 trials (± recruiting share)

Sponsors near 18% open enrollment (± trial volume)

What to do with this University Hospitals Cleveland Medical Center page

230 registered trials is a research-attention snapshot, not an endorsement of University Hospitals Cleveland Medical Center or any single study.

  • 42 of University Hospitals Cleveland Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Bipolar Disorder is the condition University Hospitals Cleveland Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Bipolar Disorder trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University Hospitals Cleveland Medical Center pipeline card: 230 registered trials from official public datasets.Report a data error.